Immediate Impact
1 by Nobel laureates 1 from Science/Nature 55 standout
Citing Papers
Targeting the tumour vasculature: from vessel destruction to promotion
2024 Standout
Randomized Study of Temozolomide or Temozolomide and Capecitabine in Patients With Advanced Pancreatic Neuroendocrine Tumors (ECOG-ACRIN E2211)
2022 Standout
Works of M. Kulke being referenced
A prospective, multi-institutional phase II study of GW786034 (pazopanib) and depot octreotide (sandostatin LAR) in advanced low-grade neuroendocrine carcinoma (LGNEC).
2010
A phase 2 study to evaluate the efficacy and safety of SU11248 in patients (pts) with unresectable neuroendocrine tumors (NETs)
2005
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| M. Kulke | 183 | 126 | 85 | 116 | 13 | 350 | |
| A. Hackshaw | 234 | 160 | 120 | 52 | 12 | 372 | |
| Matthias Ebert | 235 | 124 | 78 | 102 | 17 | 372 | |
| Pamela Sighinolfi | 163 | 128 | 17 | 96 | 14 | 378 | |
| Kyung Kee Baek | 216 | 41 | 70 | 87 | 13 | 393 | |
| Tiffany Valone | 292 | 176 | 111 | 100 | 16 | 360 | |
| Akihito Nishio | 133 | 33 | 57 | 77 | 18 | 373 | |
| Christine Challen | 186 | 30 | 110 | 212 | 13 | 372 | |
| K.D. Zang | 69 | 109 | 94 | 144 | 13 | 328 | |
| Jonathan Rock | 181 | 102 | 40 | 43 | 15 | 363 | |
| Sara M. Kloft‐Nelson | 113 | 27 | 29 | 124 | 13 | 324 |
All Works
Loading papers...